New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2014
11:57 EDTISRG, SYK, BVX, HARTIntuitive Surgical falls after guidance disappoints
Shares of Intuitive Surgical (ISRG), which makes and markets the da Vinci Surgical System, are falling after the company announced it would sell fewer systems in 2014 compared to the prior year. It also declined to provide revenue guidance for 2014. WHAT'S NEW: Last night, Intuitive Surgical reported Q4 EPS of $4.28 and revenue of $576.2M, both of which exceeded expectations of $3.83 and $558.46M, respectively. WHATíS NOTABLE: On the companyís Q4 earnings conference call, management said the company would likely sell fewer da Vinci systems in 2014 compared to 2013. It forecast 2014 procedures increasing 9%-12%, compared to a 16% increase in procedures for 2013. The company declined to provide revenue guidance for 2014, citing a lack of visibility. ANALYST REACTION: This morning, research firm Jefferies said the companyís outlook was conservative. Jefferies said that while Intuitive Surgical's lack of revenue and earnings guidance was indicative of near-term headwinds and uncertainties, its procedure guidance met expectations and was likely conservative. The firm said Intuitive's long-term growth prospects remained compelling, and it kept a Buy rating on the stock with a $480 price target. PRICE ACTION: In late morning trading, Intuitive Surgical fell $23.81, or about 5.4%, to $415.19 on heavy trading volume. The shares are down approximately 28% over the past twelve months. OTHERS TO WATCH: Intuitive Surgicalís competitors include Stryker (SYK), Bovie Medical (BVX), and Harvard Apparatus (HART).
News For ISRG;SYK;BVX;HART From The Last 14 Days
Check below for free stories on ISRG;SYK;BVX;HART the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 29, 2014
08:36 EDTISRGIntuitive Surgical receives FDA clearance for Single-Site Wristed Needle Driver
Subscribe for More Information
September 24, 2014
14:00 EDTISRGIntuitive Surgical volatility at low on tight three-month range
Subscribe for More Information
07:36 EDTISRGIntuitive Surgical stapler issue unlikely to impact results, says JPMorgan
Subscribe for More Information
September 23, 2014
10:02 EDTISRGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:17 EDTISRGIntuitive Surgical initiated with a Sector Perform at RBC Capital
Target $523.
September 22, 2014
07:50 EDTISRGDoctors continue to use morcellators despite FDA warning, J&J halt, WSJ says
Subscribe for More Information
07:47 EDTISRGIntuitive Surgical shipment halt unlikely to have major impact, says Wedbush
Subscribe for More Information
07:45 EDTISRGIntuitive Surgical stapler halt may stop momentum, says Canaccord
Canaccord said Intuitive Surgical's "stop use" notice sent to hospitals regarding its EndoWrist Stapler 45 is a negative and could halt momentum in shares. The firm remains cautious and maintains its Hold rating on Intuitive Surgical given slowing GYN growth, constrained hospital budgets, and the recent change in financial reporting.
September 18, 2014
08:37 EDTISRGIntuitive reports FDA clearance of da Vinci in benign, base of tongue procedures
Subscribe for More Information
September 17, 2014
15:19 EDTSYKStryker says targeting 60% of premium market in China by end of 2015
Says targeting 80% of premium market in China by 2020.
14:49 EDTSYKStryker says targeting dividend hike in line or above EPS growth
Subscribe for More Information
14:39 EDTSYKStryker backs Q3 adjusted EPS $1.12-$1.16, consensus $1.14
Subscribe for More Information
14:36 EDTSYKStryker says globalization remains a 'top priority'
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use